Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790376 | Urologic Oncology: Seminars and Original Investigations | 2017 | 6 Pages |
Abstract
The PPV of PI-RADS v2 for prostate cancer in patients with a single lesion on mpMRI is dependent on PI-RADS assessment category and location. The highest PPV was for a P5 lesion in the PZ.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jamil S. B.S., Kevin A. M.S., Cayce B. M.D., Ansh M. Bhagat, Steffen M.D., Angelique M.D., Peter M.D., Ph.D., Jeffrey C. M.D., Peter G. M.D., Ph.D., Preston C. M.D.,